DENTSPLY SIRONA INC (XRAY) Stock Analyst Ratings
USA - NASDAQ:XRAY - US24906P1093 - Common Stock
10.98 USD
-0.02 (-0.18%)
10.98 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 71% to XRAY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.19. This target is 47.47% above the current price.
XRAY was analyzed by 22 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about XRAY.
In the previous month the buy percentage consensus was at a similar level.
XRAY was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-07 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-28 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-26 | Needham | Reiterate | Hold -> Hold |
| 2025-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-07-21 | Needham | Reiterate | Hold -> Hold |
| 2025-05-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-04-30 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-13 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-03-13 | Needham | Downgrade | Buy -> Hold |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-28 | Needham | Maintains | Buy -> Buy |
| 2025-02-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-28 | Baird | Maintains | Neutral -> Neutral |
| 2025-02-14 | Wells Fargo | Initiate | Equal-Weight |
| 2025-02-11 | Needham | Reiterate | Buy -> Buy |
| 2025-01-30 | Needham | Maintains | Buy -> Buy |
| 2025-01-23 | Jefferies | Downgrade | Buy -> Hold |
| 2025-01-07 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-04 | Mizuho | Initiate | Neutral |
DENTSPLY SIRONA INC / XRAY FAQ
What do analysts expect the price target to be for DENTSPLY SIRONA INC (XRAY)?
22 analysts have analysed XRAY and the average price target is 16.19 USD. This implies a price increase of 47.47% is expected in the next year compared to the current price of 10.98.
How do analysts rate DENTSPLY SIRONA INC (XRAY)?
The consensus rating for DENTSPLY SIRONA INC (XRAY) is 70.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.